Radiology

Subtle Medical Receives FDA Clearance for SubtleHD™(CT), Expanding AI-Powered Image Enhancement into CT Imaging

New software enhances CT image quality across scanner generations, supporting radiologists with improved image clarity and consistency MENLO PARK, Calif., June 10, 2026 /PRNewswire/ — Subtle Medical, a leader in AI-powered medical imaging software, today announced FDA clearance for SubtleHD™(CT), an AI-powered image enhancement solution designed to reduce noise and improve low contrast […]

GE HealthCare advancing enterprise imaging with cloud-enabled solutions

CHICAGO–(BUSINESS WIRE)–GE HealthCare will showcase its latest enterprise imaging solutions at the Society for Imaging Informatics in Medicine (SIIM) 2026 Annual Meeting in Pittsburgh, PA. Medical imaging departments today are under immense pressure from all sides including rising imaging volumes and increasing case complexity, while staffing shortages continue to grow. According to the American College of Radiology (ACR), radiologist workforce shortages have been identified as the biggest th

AngioDynamics Expands Patient Access to NanoKnife IRE for Prostate and Liver Cancer as Medicare Coverage Framework Takes Effect

LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced that Palmetto GBA has issued a final Local Coverage Determination (LCD L40205) establishing Medicare coverage guidance for irreversible electroporation (IRE), the non-thermal ablation technology delivered by the Company’s NanoKnife System, in

PorTal Access, Inc. Announces Completion of FDA 510(k) Submission for Flexi-Port™, Marking Major Milestone Toward Commercial Launch

Mid-Summer Launch Anticipated for Next-Generation Oncology Vascular Access Platform MIAMI, May 18, 2026 /PRNewswire/ — PorTal Access, Inc., a medical device company pioneering next-generation vascular access solutions for oncology, today announced the successful completion of its U.S….

Butterfly Medical Secures $21 Million in Upsized Series C Funding to Advance Minimally Invasive BPH Treatment

Strategic Investment Fuels FDA Regulatory Path and Global Commercialization; Company to Showcase Technology at AUA 2026 BOSTON and YOKNEAM, Israel, May 14, 2026 /PRNewswire/ — Butterfly Medical, developer of a proprietary non-surgical solution for BPH (benign prostatic hyperplasia), today announced the successful completion of its Series C funding round, raising $21 million. The strong […]